← Leaderboards
Joel S Greenberger
University Of Pittsburgh At Pittsburgh
$22,565,586
Attributed
$23,973,265
Total exposure
23
Grants
14
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $5.6M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$68,329,355 · 24
By mechanism
U19$57,297,473 · 11
R01$5,944,145 · 4
U01$2,851,863 · 3
R42$1,015,000 · 1
R41$600,000 · 1
P50$506,705 · 2
Top collaborators
- Claude J. Rogers4 shared
- Robert J Binder1 shared
- Amitava Mukherjee1 shared
Most similar at University Of Pittsburgh At Pittsburgh
Same institution · by research overlap
- Hulya Bayir$16,376,338
- Binfeng Lu$6,521,286
- Michael W Epperly$5,121,193
- Jian Yu$10,881,915
- Derek A Pociask$2,330,869
Others in their field
Top investigators on “Radiation”
- Philip J Disaia · University Of California Irvine$135,204,929
- Walter John Curran · Thomas Jefferson University$132,574,833
- Richard L Schilsky · University Of Chicago$122,521,723
- Polly Chang · Sri International$120,948,376
- Maury Tigner · Cornell University$104,613,212
- Norman Wolmark · Nsabp Foundation, Inc.$104,551,329
Research focus
RadiationIrradiationPharmaceutical PreparationsCellsProgramsPlasmidsMitochondriaRadiation ProtectionLiposomesStem CellsAntioxidantsLungFundingFemaleTissuesSmall MoleculeWhole-Body IrradiationDrug Delivery SystemsResearch PersonnelAcuteUniversitiesGene TherapyIntestinesDose
Grant awards (108)
Mitigation of Ionizing Irradiation-Induced Intestinal Damage by Second-Generation Probiotic LR-IFN-β$1,015,000
R42 · FY2025 · AI
Mitigation of hematopoietic acute radiation syndrome (ARS) by inhibition of tyrosine kinase Fgr$547,537
U01 · FY2025 · AI
LR-IL-22 for Mitigation and Management of Radiation Injuries$529,087
U01 · FY2025 · AI · contact PI
Investigation of the mechanisms of H-ARS mitigation by the orally administrated GI-ARS mitigator LR-IFN-beta$470,309
U01 · FY2025 · AI
LR-IL-22 for Mitigation and Management of Radiation Injuries$99,639
U01 · FY2025 · AI · contact PI
LR-IL-22 for Mitigation and Management of Radiation Injuries$545,451
U01 · FY2024 · AI · contact PI
LR-IL-22 for Mitigation and Management of Radiation Injuries$99,639
U01 · FY2024 · AI · contact PI
LR-IL-22 for Mitigation and Management of Radiation Injuries$560,201
U01 · FY2023 · AI · contact PI
Mitigation of Ionizing Irradiation-Induced Intestinal Damage by Second-Generation Probiotics LR-IL-22 and LR-IFN-β$300,000
R41 · FY2022 · AI
Mitigation of Ionizing Irradiation-Induced Intestinal Damage by Second-Generation Probiotics LR-IL-22 and LR-IFN-β$300,000
R41 · FY2021 · AI
Signature-Directed, Sequential Delivery of Radiation Mitigators$3,667,379
U19 · FY2019 · AI · contact PI
Signature-Directed Combination Mitigator Therapy Based on GS-Nitroxides$450,547
U19 · FY2019 · AI · contact PI
Coordinating Center Core$409,483
U19 · FY2019 · AI · contact PI
Administrative Core$98,825
U19 · FY2019 · AI · contact PI
Signature-Directed, Sequential Delivery of Radiation Mitigators$3,985,081
U19 · FY2018 · AI · contact PI
Signature-Directed Combination Mitigator Therapy Based on GS-Nitroxides$560,363
U19 · FY2018 · AI · contact PI
Administrative Core$400,189
U19 · FY2018 · AI · contact PI
Coordinating Center Core$97,908
U19 · FY2018 · AI · contact PI
Signature-Directed, Sequential Delivery of Radiation Mitigators$3,839,379
U19 · FY2017 · AI · contact PI
Signature-Directed Combination Mitigator Therapy Based on GS-Nitroxides$472,947
U19 · FY2017 · AI · contact PI
Coordinating Center Core$418,763
U19 · FY2017 · AI · contact PI
Administrative Core$102,454
U19 · FY2017 · AI · contact PI
Signature-Directed, Sequential Delivery of Radiation Mitigators$4,142,379
U19 · FY2016 · AI · contact PI
Administrative Core$572,435
U19 · FY2016 · AI · contact PI
Signature-Directed Combination Mitigator Therapy Based on GS-Nitroxides$449,786
U19 · FY2016 · AI · contact PI
Coordinating Center Core$397,927
U19 · FY2016 · AI · contact PI
Signature-Directed, Sequential Delivery of Radiation Mitigators$3,667,379
U19 · FY2015 · AI · contact PI
Signature-Directed Combination Mitigator Therapy Based on GS-Nitroxides$449,786
U19 · FY2015 · AI · contact PI
Coordinating Center Core$398,254
U19 · FY2015 · AI · contact PI
Administrative Core$97,435
U19 · FY2015 · AI · contact PI
Mitochondrial Target for Radiation Mitigation$2,827,181
U19 · FY2014 · AI · contact PI
Pilot Project's Core$498,023
U19 · FY2014 · AI · contact PI
Mitochondrial Targeted Small Molecule Radiation Mitigators$270,540
U19 · FY2014 · AI · contact PI
Administrative Core$50,693
U19 · FY2014 · AI · contact PI
Mitochondrial Target for Radiation Mitigation$2,715,213
U19 · FY2013 · AI · contact PI
Pilot Project's Core$473,678
U19 · FY2013 · AI · contact PI
Mitochondrial Targeted Small Molecule Radiation Mitigators$251,207
U19 · FY2013 · AI · contact PI
Administrative Core$48,012
U19 · FY2013 · AI · contact PI
Mitochondrial Target for Radiation Mitigation$3,363,048
U19 · FY2012 · AI · contact PI
Mitochondrial Targeted Small Molecule Radiation Mitigators$878,470
U19 · FY2012 · AI · contact PI
Pilot Project's Core$462,629
U19 · FY2012 · AI · contact PI
Mechanism of Irradiation Pulmonary Fibrosis$282,705
R01 · FY2012 · CA · contact PI
Administrative Core$46,551
U19 · FY2012 · AI · contact PI
Mitochondrial Target for Radiation Mitigation$2,743,404
U19 · FY2011 · AI · contact PI
Pilot Project's Core$410,796
U19 · FY2011 · AI · contact PI
Mechanism of Irradiation Pulmonary Fibrosis$282,705
R01 · FY2011 · CA · contact PI
Mitochondrial Targeted Small Molecule Radiation Mitigators$251,570
U19 · FY2011 · AI · contact PI
Administrative Core$124,630
U19 · FY2011 · AI · contact PI
Mitochondrial Target for Radiation Mitigation$2,780,452
U19 · FY2010 · AI · contact PI
Pilot Project's Core$414,594
U19 · FY2010 · AI · contact PI
Mechanism of Irradiation Pulmonary Fibrosis$291,448
R01 · FY2010 · CA · contact PI
Mitochondrial Targeted Small Molecule Radiation Mitigators$250,096
U19 · FY2010 · AI · contact PI
Gene Therapy Reduction of Radiotherapy Esophagitis$216,182
R01 · FY2010 · CA · contact PI
Administrative Core$124,561
U19 · FY2010 · AI · contact PI
CAREER DEVELOPMENT PROGRAM$108,778
P50 · FY2010 · CA · contact PI
Mitochondrial Targeting Against Radiation Damage$2,081,287
U19 · FY2009 · AI · contact PI
Manganese superoxide dismutase transgene product and SOD mimetic small molecules$323,957
U19 · FY2009 · AI · contact PI
Mitochondrial Targeting Against Radiation Damage$300,000
U19 · FY2009 · AI · contact PI
Mechanism of Irradiation Pulmonary Fibrosis$291,448
R01 · FY2009 · CA · contact PI
Gene Therapy Reduction of Radiotherapy Esophagitis$216,561
R01 · FY2009 · CA · contact PI
Core--Pilot Research Projects$145,416
U19 · FY2009 · AI · contact PI
Training and Education$119,144
U19 · FY2009 · AI · contact PI
CAREER DEVELOPMENT PROGRAM$108,785
P50 · FY2009 · CA · contact PI
Mitochondrial Targeting Against Radiation Damage$2,024,600
U19 · FY2008 · AI · contact PI
Manganese superoxide dismutase transgene product and SOD mimetic small molecules$314,551
U19 · FY2008 · AI · contact PI
Mechanism of Irradiation Pulmonary Fibrosis$291,448
R01 · FY2008 · CA · contact PI
MnSOD-PL Irradiation Protection of the Oral Cavity$230,171
R01 · FY2008 · CA · contact PI
Gene Therapy Reduction of Radiotherapy Esophagitis$216,761
R01 · FY2008 · CA · contact PI
Core--Pilot Research Projects$144,976
U19 · FY2008 · AI · contact PI
Training and Education$115,626
U19 · FY2008 · AI · contact PI
CAREER DEVELOPMENT PROGRAM$109,040
P50 · FY2008 · CA · contact PI
Mitochondrial Targeting Against Radiation Damage$2,207,718
U19 · FY2007 · AI · contact PI
Manganese superoxide dismutase transgene product and SOD mimetic small molecules$304,815
U19 · FY2007 · AI · contact PI
MnSOD-PL Irradiation Protection of the Oral Cavity$230,302
R01 · FY2007 · CA · contact PI
Gene Therapy Reduction of Radiotherapy Esophagitis$216,615
R01 · FY2007 · CA · contact PI
Core--Pilot Research Projects$180,167
U19 · FY2007 · AI · contact PI
Training and Education$155,108
U19 · FY2007 · AI · contact PI
CAREER DEVELOPMENT PROGRAM$110,102
P50 · FY2007 · CA · contact PI
Mitochondrial Targeting Against Radiation Damage$2,011,590
U19 · FY2006 · AI · contact PI
Manganese SOD transgene product and SOD small molecules$274,898
U19 · FY2006 · AI · contact PI
MnSOD-PL Irradiation Protection of the Oral Cavity$233,584
R01 · FY2006 · CA · contact PI
Gene Therapy Reduction of Radiotherapy Esophagitis$222,937
R01 · FY2006 · CA · contact PI
Core--Pilot Research Projects$159,373
U19 · FY2006 · AI · contact PI
Training and Education$132,659
U19 · FY2006 · AI · contact PI
CAREER DEVELOPMENT PROGRAM$70,000
P50 · FY2006 · CA · contact PI
Mitochondrial Targeting Against Radiation Damage$2,000,000
U19 · FY2005 · AI
Manganese SOD transgene product and SOD small molecules$251,200
U19 · FY2005 · AI
MnSOD-PL Irradiation Protection of the Oral Cavity$239,205
R01 · FY2005 · CA
Gene Therapy Reduction of Radiotherapy Esophagitis$231,296
R01 · FY2005 · CA
Lung Radiation Protection by MnSOD Transgene Therapy$226,370
R01 · FY2005 · HL
Core--Pilot Research Projects$156,476
U19 · FY2005 · AI
Training and Education$127,627
U19 · FY2005 · AI
Administrative$102,238
U19 · FY2005 · AI
Gene Therapy Reduction of Radiotherapy Esophagitis$231,371
R01 · FY2004 · CA
Lung Radiation Protection by MnSOD Transgene Therapy$227,660
R01 · FY2004 · HL
Gene Therapy Reduction of Radiotherapy Esophagitis$232,207
R01 · FY2003 · CA
Lung Radiation Protection by MnSOD Transgene Therapy$229,164
R01 · FY2003 · HL
Gene Therapy Reduction of Radiotherapy Esophagitis$233,042
R01 · FY2002 · CA
Lung Radiation Protection by MnSOD Transgene Therapy$230,658
R01 · FY2002 · HL
STEM CELL AGE &XRAY CHEMOTHERAPY &LEUKEMOGENESIS$0
P41 · FY2002 · RR
PROTECTION OF ESOPHAGUS/NORMAL LUNG FROM RADIOTHERAPY$0
P50 · FY2002 · CA
STEM CELL AGE &XRAY CHEMOTHERAPY &LEUKEMOGENESIS$0
P41 · FY2002 · RR
Gene Therapy Reduction of Radiotherapy Esophagitis$233,077
R01 · FY2001 · CA
LUNG RADIATION PROTECTION BY MNSOD--TRANSGENE THERAPY$206,624
R01 · FY2001 · HL
PROTECTION OF ESOPHAGUS/NORMAL LUNG FROM RADIOTHERAPY$0
P50 · FY2001 · CA
STEM CELL AGE &XRAY CHEMOTHERAPY &LEUKEMOGENESIS$0
P41 · FY2001 · RR
LUNG RADIATION PROTECTION BY MNSOD--TRANSGENE THERAPY$200,604
R01 · FY2000 · HL
Bone marrow stromal cells for myoblast transplantation$114,169
P60 · FY2000 · AR